stockrowSotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
Follow SHC
Alert me
Sotera Health Company (SHC) Net income
Sotera Health Company's net income for fiscal 2025 was $77.9M, up 75.6% from $44.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $173.5M. Over the past ten years it has ranged from −$233.6M (fiscal 2022) to $117.1M (fiscal 2021); the current reading is higher than 89% of that period. Sotera Health Company ranks 14th of 49 Diagnostics & Research companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $77.9M | 75.57% |
| FY2024 | $44.4M | (13.58%) |
| FY2023 | $51.4M | — |
| FY2022 | −$233.6M | — |
| FY2021 | $117.1M | — |
| FY2020 | −$37.5M | — |
| FY2019 | −$20.4M | — |
| FY2018 | −$5.9M | — |
| FY2017 | $0.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $58.4M | 8.85% |
| Jun 2026 | $53.6M | 101.75% |
| Mar 2026 | $26.6M | (23.70%) |
| Dec 2025 | $34.8M | (28.00%) |
| 26 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| QGEN QIAGEN N.V. compare | $409.3M |
| SHC Sotera Health Company | $173.5M |
| CDNA CareDx, Inc. compare | $128.6M |
| VCYT Veracyte, Inc. compare | $126.8M |
| BLLN BillionToOne, Inc. compare | $49.4M |
| RDNT RadNet, Inc. compare | $19.3M |
| NEO NeoGenomics, Inc. compare | −$32.3M |
| ADPT Adaptive Biotechnologies Corporation compare | −$70.7M |
| GRAL GRAIL, Inc. compare | −$406.2M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on SHC
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement